The Bull Case For agilon health (AGL) Could Change Following Strong 2024 REACH ACO Savings And Quality

Simply Wall St.07-12 06:20

In 2024, agilon health reported that its eight REACH Accountable Care Organizations generated US$229 million in gross savings and achieved a 96% average quality score while managing care for about 121...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2650115795?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957","is_english":true,"pubTime":"2026-07-12 06:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2650115795","market":"sg","top_or_hot":-1,"title":"The Bull Case For agilon health (AGL) Could Change Following Strong 2024 REACH ACO Savings And Quality","media":"Simply Wall St.","content":"<div>\n<p>In 2024, agilon health reported that its eight REACH Accountable Care Organizations generated US$229 million in gross savings and achieved a 96% average quality score while managing care for about 121...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-agl/agilon-health/news/the-bull-case-for-agilon-health-agl-could-change-following-s\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>The Bull Case For agilon health (AGL) Could Change Following Strong 2024 REACH ACO Savings And Quality</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThe Bull Case For agilon health (AGL) Could Change Following Strong 2024 REACH ACO Savings And Quality\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-07-12 06:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nyse-agl/agilon-health/news/the-bull-case-for-agilon-health-agl-could-change-following-s><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>In 2024, agilon health reported that its eight REACH Accountable Care Organizations generated US$229 million in gross savings and achieved a 96% average quality score while managing care for about 121...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-agl/agilon-health/news/the-bull-case-for-agilon-health-agl-could-change-following-s\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"VTHR","symbol_name":"Vanguard Russell 3000 ETF","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-agl/agilon-health/news/the-bull-case-for-agilon-health-agl-could-change-following-s","article_id":"2650115795","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-agl/agilon-health/news/the-bull-case-for-agilon-health-agl-could-change-following-s","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2650115795","pubTimestamp":1783808452,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"In 2024, agilon health reported that its eight REACH Accountable Care Organizations generated US$229 million in gross savings and achieved a 96% average quality score while managing care for about 121,000 Traditional Medicare beneficiaries under full-risk contracts.\nThis combination of substantial cost savings for Medicare and consistently high quality scores offers a concrete data point on how agilon health’s value-based model can align physician incentives with better outcomes for...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"VTHR":"Vanguard Russell 3000 ETF","BK4196":"保健护理服务","BK4539":"次新股","AGL.AU":"AGL ENERGY LTD","AIPO":"Defiance AI and Power Infrastructure ETF","CHAT":"ROUNDHILL GENERATIVE AI & TECHNOLOGY ETF","AGL":"agilon health, inc.","BK7136":"复合型公用事业","QTOC":"Innovator Growth Accelerated Plus ETF - October","AGIX":"通用人工智能 ETF-AGIX","ARTY":"ISHARES FUTURE AI & TECH ETF"},"translate_title":"在 2024 年实现 ACO 节约和质量强劲之后，agilon health (AGL) 的牛市情况可能会发生变化","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VTHR":0.62,"AGIX":0.62,"CHAT":0.62,"ARTY":0.62,"QTOC":0.62,"AGL.AU":1.5,"AIPO":0.73,"AGL":1.5},"content_text":"In 2024, agilon health reported that its eight REACH Accountable Care Organizations generated US$229 million in gross savings and achieved a 96% average quality score while managing care for about 121,000 Traditional Medicare beneficiaries under full-risk contracts. This combination of substantial cost savings for Medicare and consistently high quality scores offers a concrete data point on how agilon health’s value-based model can align physician incentives with better outcomes for seniors. We’ll now examine how this REACH ACO savings and quality performance reshapes agilon health’s investment narrative and future risk-reward profile. Invest in the nuclear renaissance through our list of 89 elite nuclear energy infrastructure plays powering the global AI revolution.Advertisementagilon health Investment Narrative RecapTo be comfortable owning agilon health, you have to believe its value-based model can consistently turn clinical performance into sustainable economics, despite recent volatility in membership, margins, and leadership. The REACH ACO results are encouraging, but they do not directly resolve near term concerns around risk adjustment revenue, payer renegotiations for 2026, or cost trends in inpatient and oncology drugs, so their impact on the key short term catalyst and the biggest risk appears limited for now. The REACH ACO announcement sits alongside agilon health’s recent 1-for-25 reverse stock split, executed in March 2026 to lift the share price and maintain NYSE listing. For investors tracking catalysts, that split, combined with the strong price move since, highlights how sensitive the stock can be to shifts in sentiment, even as underlying operational issues like medical margins and contracting economics remain central to the story. Yet beneath the REACH savings headline, investors should be aware that... Read the full narrative on agilon health (it's free!)agilon health's narrative projects $7.0 billion revenue and $42.4 million earnings by 2029.Uncover how agilon health's forecasts yield a $60.36 fair value, a 47% downside to its current price.Exploring Other PerspectivesAGL 1-Year Stock Price Chart While the REACH savings highlight clinical success, the most pessimistic analysts were assuming only about 2.1 percent annual revenue growth and no profitability within three years, underscoring how sharply views on agilon health’s future can differ and why it is worth comparing multiple scenarios before deciding where you stand.Explore 4 other fair value estimates on agilon health - why the stock might be a potential multi-bagger!Decide For YourselfDon't just follow the ticker - dig into the data and build a conviction that's truly your own.A great starting point for your agilon health research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.Our free agilon health research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate agilon health's overall financial health at a glance.No Opportunity In agilon health?Every day counts. These free picks are already gaining attention. See them before the crowd does:Capitalize on the AI infrastructure supercycle with our selection of the 52 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.Uncover the next big thing with 20 elite penny stocks that balance risk and reward.Explore 26 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: AI Stock Screener & AlertsOur new AI Stock Screener scans the market every day to uncover opportunities.• Dividend Powerhouses (3%+ Yield)• Undervalued Small Caps with Insider Buying• High growth Tech and AI CompaniesOr build your own from over 50 metrics.Explore Now for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2650115795","isCrawlerRequest":true}